Speakers 2017
-
HEPATITIS C - SESSION 2 (chairman)
-
(chairman)
Presentation
-
AMADDEO Giuliana
France
-
Les antiviraux directs favorisent-ils la survenue du carcinome hépatocellulaire chez les patients infectés par le VHC ?
Presentation
-
-
Why and how to assess renal function in cirrhosis
-
Presentation
-
ARTRU Florent
France
-
L’infection chez le cirrhotique
Presentation
-
-
Universal Hepatitis C treatment: strategies for simplification
-
STATE OF THE ART LECTURE (chairman)
Presentation
-
BARRAULT Camille
France
-
L’infection chez le cirrhotique (chairman)
-
RESTITUTION DES ATELIERS
Presentation
-
BAUMERT Thomas
France
-
Principaux apports des sciences fondamentales en hépatologie
Presentation
-
-
-
Pathology of NASH
Presentation
-
-
Epidemiology of NASH
Presentation
-
-
-
OTHER COUNTRIES
Presentation
-
-
Management of cholestatic diseases in 2017
Presentation
-
-
Prevention and treatment of variceal hemorrhage in 2017
Presentation
-
-
HEPATITIS C - SESSION 1 (chairman)
-
Take home messages
Presentation
-
-
PRÉSENTATIONS DE TRAVAUX DE JUNIORS
Presentation
-
BRUIX Jordi
Spain
-
(chairman)
-
HCC SESSION (chairman)
-
The impact of anti HCV DAAs on HCC
Presentation
-
-
WESTERN COUNTRIES
-
Presentation
-
-
(chairman)
Presentation
-
CALDERARO Julien
France
-
PD-1 et carcinome hépatocellulaire
Presentation
-
CARDOSO Ana Carolina
Brazil
Presentation
-
Presentation
-
CHEVALIEZ Stéphane
France
Presentation
-
-
(chairman)
-
Introduction (chairman)
-
WESTERN COUNTRIES (chairman)
-
HCC SESSION (chairman)
Presentation
-
-
HEPATITIS C - SESSION 2 (chairman)
-
WESTERN COUNTRIES
Presentation
-
-
WESTERN COUNTRIES
Presentation
-
-
(chairman)
Presentation
-
DI MARTINO Vincent
France
-
RESTITUTION DES ATELIERS
-
Presentation
-
-
The future of liver transplantation for viral hepatitis
Presentation
-
DUSHEIKO Geoffrey
UK
-
Impact of therapy on the QOL
-
Presentation
-
-
Follow-up of the Georgian and Egyptian programs
Presentation
-
-
HEPATITIS C - SESSION 1 (chairman)
Presentation
-
-
(chairman)
Presentation
-
FLISIAK Robert
Poland
-
Results in real life
-
OTHER COUNTRIES
Presentation
-
-
(chairman)
-
WESTERN COUNTRIES
-
TWO PROGRAMS OF HCV ERADICATION
Presentation
-
Presentation
-
-
WESTERN COUNTRIES
-
OTHER COUNTRIES (chairman)
-
Take home messages
Presentation
-
GANE Edward
New Zealand)
-
New anti-HBV strategies
-
(chairman)
Presentation
-
GARIOUD Armand
France
-
Lithiase biliaire et génétique (chairman)
-
RESTITUTION DES ATELIERS
Presentation
-
GOOSSENS Nicolas
France
-
Intérêts des biomarqueurs dans la prédiction et la prise en charge du CHC (chairman)
-
RESTITUTION DES ATELIERS
Presentation
-
GUILLAUME Maéva
France
-
Lithiase biliaire et génétique
Presentation
-
GUYADER Dominique Dominique
France
-
Controverses (chairman)
Presentation
-
Presentation
-
HATZAKIS Angelos
Greece
-
Policies for HCV elimination
Presentation
-
Presentation
-
HOU Jinlin
Chine
-
OTHER COUNTRIES
Presentation
-
-
OTHER COUNTRIES
-
Presentation
-
-
HEPATITIS B - SESSION 1 (chairman)
Presentation
-
-
Long term impact of antiviral therapy (NUCs)
Presentation
-
LANNES Adrien
France
-
Méthodes diagnostiques de la NASH
Presentation
-
-
-
How to manage HBV patients in 2017?
Presentation
-
LEGROS Ludivine
France
-
Prise en charge de l’hypertension porto-pulmonaire
Presentation
-
LEQUOY Marie
France
-
Les antiviraux directs favorisent-ils la survenue du carcinome hépatocellulaire chez les patients infectés par le VHC ?
Presentation
-
LEROY Vincent
France
-
Traitement de l’hépatite C en 2017 et recommandations
-
Presentation
-
-
PRÉSENTATIONS DE TRAVAUX DE JUNIORS
-
Presentation
-
LIM Annie
France
-
Intérêts des biomarqueurs dans la prédiction et la prise en charge du CHC
Presentation
-
LIM Seng Gee
Singapore
-
When can we stop NUCS in patients with chronic hepatitis B?
Presentation
-
MANNS Michael
Germany
-
HEPATITIS B - SESSION 2 (chairman)
-
How to improve access to therapy for HBV patients?
-
(chairman)
Presentation
-
-
Introduction
-
Conférence (chairman)
-
Conférence (chairman)
-
Conclusion
-
Introduction
-
STATE OF THE ART LECTURE & AWARD (chairman)
-
Conclusion
-
Introduction
-
Conclusion
Presentation
-
MATHURIN Philippe
France
Presentation
-
-
END-STAGE LIVER DISEASE (chairman)
Presentation
-
NINGARHARI Massih
France
-
Intérêts des biomarqueurs dans la prédiction et la prise en charge du CHC
Presentation
-
Presentation
-
PAGEAUX Georges-Philippe
France
-
Après l’hépatite C, quel avenir pour l’hépatologie ?
-
(chairman)
Presentation
-
PAIS Raluca
France
-
Méthodes diagnostiques de la NASH (chairman)
-
RESTITUTION DES ATELIERS
-
Presentation
-
-
HEPATITIS B - SESSION 1 (chairman)
-
(chairman)
Presentation
-
-
-
OTHER COUNTRIES
Presentation
-
PARLATI Lucia
France
-
Acides biliaires et obésité
Presentation
-
PAWLOTSKY Jean-Michel
France
-
Place de la virologie à l’heure des antiviraux directs
Presentation
-
PERLEMUTER Gabriel
France
-
Le microbiote : de la pathogénie au traitement des maladies du foie
-
Presentation
-
-
HÉPATITES VIRALES (chairman)
-
(chairman)
Presentation
-
-
OTHER COUNTRIES
-
Presentation
-
RATZIU Vlad
France
-
(chairman)
-
Lifestyle intervention in NASH
Presentation
-
Presentation
-
RICE Charles
USA
-
The future of research on viral hepatitis
Presentation
-
ROUX Olivier
France
-
Béta bloquant et hémodynamique chez le cirrhotique
Presentation
-
RUIZ CHAVEZ Isaac
France
-
Peut-on arrêter les NUC chez les patients VHB ?
Presentation
-
-
Controverses (chairman)
-
END-STAGE LIVER DISEASE (chairman)
-
Reconsidering OLT to treat HCC in an era of donors shortage
Presentation
-
-
(chairman)
-
NASH SESSION (chairman)
-
Therapies in NASH
Presentation
-
-
HEPATITIS B - SESSION 2 (chairman)
Presentation
-
-
Impact of therapy in a patient F1
Presentation
-
-
From HCV to HBV cure
Presentation
-
SERFATY Lawrence
France
-
Conférence (chairman)
-
RESTITUTION DES ATELIERS
-
HÉPATITES VIRALES (chairman)
-
NASH SESSION (chairman)
-
(chairman)
Presentation
-
-
Impact of therapy on metabolism and public health
-
Presentation
-
SUBIC-LEVRERO Miroslava
France
-
Peut-on arrêter les NUC chez les patients VHB ?
Presentation
-
-
Intérêts des antiviraux directs dans la cirrhose virale C décompensée
-
Presentation
-
-
(chairman)
Presentation
-
TSERTSVADZE Tengiz
Georgia
-
Follow-up of the Georgian and Egyptian programs
Presentation
-
URBANEK Petr
Czech Republic
Presentation
-
URSIC BEDOYA José
France
-
L’infection chez le cirrhotique
Presentation
-
VERRIER Eloi
France
-
L’entrée cellulaire du VHB et du VHD
Presentation
-
VOICAN Cosmin
France
-
Méthodes diagnostiques de la NASH
Presentation
-
WEIL-VERHOEVEN Delphine
France
-
Pronostic du cirrhotique admis en réanimation
Presentation
-
YAZDANPANAH Yazdan
France
Presentation
-
ZEUZEM Stefan
Germany
-
Special populations
-
WESTERN COUNTRIES
Presentation
-
ZOULIM Fabien
France
-
New targets for HBV therapies
Presentation
-
-
The molecular road map of HCC
Presentation
-
